Latus
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Level2 710 Collins St, Williams Landing,...Phone Number
+61 361206131Website
www.latus.edu.auRevenue
$5.6 MillionIndustry
About Latus
Latus Org Chart
Is Latus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Latus has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Latus recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Latus has new funding data
Latus, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Latus had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Latus
Check out if Latus is spiking on competitors!
Product Launch: Get notified when Latus launches new products
Recommended Actions
Reach out to Masked Content who joined Latus as Masked Content
Find 2 more new buyers
Compare Similar Companies to Latus
Compare insights from companies similar to Latus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Latus is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Latus is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Latus.
Latus Tech Stack
A closer look at the technologies used by Latus
Latus News & Media
Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing
PHILADELPHIA--(BUSINESS WIRE)--Latus Bio, Inc. (“Latus”), a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch and an initial close of $54 million in Series A financing. The funding round is being led by 8VC and DCVC Bio. To date, Samsung Life Science Fund (created by Samsung C&T, Samsung Biologics, Samsung Bioepis and Samsung Venture Investment Corporation), The Children’s Hospital of Philadelphia Fou
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Latus
LATUS - Risk Compliance Specialists provides businesses with practical solutions to streamline operations, manage risk, and achieve compliance. Their expertise spans logistics, auditing, training, and strategic management, aimed at enhancing organizational performance and safety. They serve clients across Australia, New Zealand, and South East Asia... Read More